Why These Two Kits Require Different Protocols, Mechanistic Comparison
🔵 QuickTest Format, FineTest QT-EH1581
The QuickTest plate is coated with an anti-tag secondary antibody, not the capture antibody directly. The Cap/Det Ab reagent contains both the tagged capture antibody and the biotin-detection antibody in a single pre-mixed solution.
Faster because antibody–antigen kinetics are faster in solution than at solid phase.
🟠 Standard Sandwich Format, CUSABIO CSB-EL007460HU
Capture antibody is directly pre-coated on the microplate. Sample antigen binds the immobilized capture antibody in solid-phase. Detection antibody and HRP conjugate are added in sequential separate steps.
More sensitive because each step reaches equilibrium independently. Trade-off: ~4 h total time.
Inter-CV: 4.25–4.77%
Before You Begin, Reagent Preparation
| Tube | Zero | 1/2 | 1/4 | 1/8 | 1/16 | 1/32 | 1/64 | Blank |
|---|---|---|---|---|---|---|---|---|
| ng/ml | 20* | 10 | 5 | 2.5 | 1.25 | 0.625 | 0.312 | 0 |
| Loaded as | S8 | S7 | S6 | S5 | S4 | S3 | 0 ng/ml |
| STD (ng/ml) | OD-1 | OD-2 | Average OD | Corrected OD* |
|---|---|---|---|---|
| 0 | 0.119 | 0.123 | 0.121 | 0 |
| 0.156 | 0.180 | 0.178 | 0.179 | 0.058 |
| 0.312 | 0.208 | 0.204 | 0.206 | 0.085 |
| 0.625 | 0.310 | 0.307 | 0.296 | 0.175 |
| 1.25 | 0.495 | 0.491 | 0.469 | 0.348 |
| 2.5 | 0.695 | 0.699 | 0.715 | 0.594 |
| 5 | 1.444 | 1.457 | 1.419 | 1.298 |
| 10 | 2.286 | 2.232 | 2.247 | 2.126 |
Assay Procedure, 4 Steps, 120 Minutes
× 2 cycles
× 5 cycles
Performance Validation Data, QT-EH1581 (FineTest)
| Sample | Mean ng/ml | Intra-CV% | Inter-CV% |
|---|---|---|---|
| Low | 0.29 / 0.31 | 4.19% | 4.77% |
| Mid | 1.16 / 1.25 | 3.97% | 4.32% |
| High | 5.07 / 4.99 | 3.62% | 4.25% |
| Matrix | Range (%) | Average (%) |
|---|---|---|
| Serum | 87–97% | 92% |
| EDTA Plasma | 86–98% | 91% |
| Heparin Plasma | 90–101% | 94% |
| Matrix | 1:2 | 1:4 | 1:8 |
|---|---|---|---|
| Serum | 86–105% | 84–98% | 82–93% |
| EDTA Plasma | 86–98% | 82–101% | 80–98% |
| Heparin Plasma | 89–104% | 84–97% | 82–100% |
Inter-CV: <10%
LLD: <0.039 ng/ml
Before You Begin, Reagent Preparation
| Tube | S7 | S6 | S5 | S4 | S3 | S2 | S1 | S0 |
|---|---|---|---|---|---|---|---|---|
| ng/ml | 10 | 5 | 2.5 | 1.25 | 0.625 | 0.312 | 0.156 | 0 |
Assay Procedure, 5 Steps, ~4 Hours
2 min soak
× 3 cycles
2 min soak
× 5 cycles
Performance Specifications, CSB-EL007460HU (CUSABIO)
| Metric | CV Specification |
|---|---|
| Intra-assay | <8% |
| Inter-assay | <10% |
| Parameter | Value |
|---|---|
| Lower Limit of Detection (LLD) | <0.039 ng/ml |
| Method | Mean + 3 SD of 20× zero standard replicates |
| Parameter | 🔵 FineTest QT-EH1581 (QuickTest) | 🟠 CUSABIO CSB-EL007460HU (Standard) |
|---|---|---|
| Format / Mechanism | Solution-phase sandwich capture (QuickTest) Cap+Det Ab co-incubated with sample; complex captured onto plate via anti-tag
|
Classical solid-phase sandwich ELISA Capture Ab pre-coated; antigen captured in solid phase; detection Ab added sequentially
|
| Total Run Time | 120 min ✓ Faster | ~240 min (4 h) |
| Detection Range | 0.156 – 10 ng/ml | 0.156 – 10 ng/ml |
| Sensitivity (LOD/LLD) | 0.094 ng/ml | <0.039 ng/ml ✓ More sensitive |
| Sample Volume/Well | 50 µl | 100 µl |
| Sample Types Validated | Serum, plasma, cell culture supernatant, cell lysate, tissue lysate, other biological fluids | Serum, plasma, tissue homogenates, cell lysates |
| Standard Reconstitution | 0.5 ml Sample Diluent → 20 ng/ml stock Serial 1:2, 150 µl transfers; 8 points
|
1.0 ml Sample Diluent → 10 ng/ml stock Serial 1:2, 250 µl transfers; 8 points
|
| Step 1 Incubation | 60 min @ 37°C Cap/Det Ab + Sample simultaneously
|
2 h @ 37°C Sample only; no wash after this step
|
| Step 2 Incubation | 30 min @ 37°C HRP-Streptavidin (ready-to-use)
|
1 h @ 37°C Biotin-antibody (100× → dilute to 1×)
|
| Step 3 Incubation |
Only 2 incubation steps in assay
|
1 h @ 37°C HRP-Avidin (100× → dilute to 1×)
|
| Wash Protocol | Wash × 2 after Step 1 Wash × 5 after Step 2 300–350 µl/well, no immersion
|
No wash after Step 1 capture Wash × 3 after Step 2 (200 µl, 2-min soak) Wash × 5 after Step 3 |
| TMB Development | 90 µl, 10–20 min @ 37°C, dark | 90 µl, 15–30 min @ 37°C, dark |
| Stop + Read | 50 µl Stop → 450 nm (read immediately) Optional correction: 570 or 630 nm
|
50 µl Stop → 450 nm within 5 min Optional correction: 540 or 570 nm
|
| Intra-assay CV | 3.62–4.19% (measured) ✓ | <8% (specification) |
| Inter-assay CV | 4.25–4.77% (measured) ✓ | <10% (specification) |
| Recovery | Serum: 87–97% (avg 92%) EDTA Plasma: 86–98% (avg 91%) Heparin Plasma: 90–101% (avg 94%) |
Not reported in datasheet |
| Curve Fitting | 4-PL logistic (recommended) Free online tool: elisa.fn-test.com
|
4-PL logistic (recommended) CurveExpert or equivalent software
|
| Dilution Correction Note | Undiluted samples: multiply result × 2 (on-plate 1:1 dilution by Cap/Det Ab). Pre-diluted at 1:100: multiply × 200. | Multiply by dilution factor only (no inherent in-well dilution). |
| Best Use Case | High throughput, time-constrained runs. Strong precision data, validated recovery across 3 matrices. Suitable when sensitivity >0.094 ng/ml is sufficient. | Low-abundance targets requiring maximum sensitivity. <0.039 ng/ml LLD. Appropriate when EFNA1 levels expected near or below 0.1 ng/ml range. |
| Problem | Likely Cause | Resolution |
|---|---|---|
| No signal (standard + samples) | Incorrect reagent addition order; missing step; mixed kit components | Verify each step was completed in sequence. Use only components from the same kit lot. Repeat assay with fresh reagents. |
| Overflow OD (all wells saturated) | Cross-contaminated kit components; over-concentrated working solutions | Confirm reagent dilutions (particularly for CUSABIO: 100× concentrate must be diluted 1:100). Use only same-kit components. |
| No signal from samples (standards OK) | Sample concentration below detection range; incompatible lysis buffer; excessive freeze-thaw | Decrease dilution ratio or concentrate sample. For lysates: avoid NP-40, Triton X-100, DTT. Aliquot samples to avoid freeze-thaw cycles. |
| High CV% (poor reproducibility) | Uneven washing; foaming in wells; inconsistent pipetting; precipitate in wells | Use calibrated multichannel pipette. Increase dilution to reduce precipitate. Ensure washer tubing is unobstructed. Check pipettor calibration. |
| Low standard curve signal | Improperly reconstituted standard; degraded standard; over-dried plate after washing | Centrifuge lyophilized standard before opening. Follow storage conditions strictly. Never allow wells to dry, add reagents immediately after each wash. |
| High background | Insufficient washing; contaminated wash buffer; TMB exposed to light; reading delayed after Stop Solution | Complete all prescribed wash cycles. Prepare fresh wash buffer. Incubate TMB step in dark. Read within 5 minutes of adding Stop Solution. |
| Poor standard curve fit | Inappropriate curve fitting model; standard preparation error | Use 4-PL logistic fitting. Try alternative models if 4-PL fit is poor. Verify serial dilution volumes and mixing at each step. Exclude outlier replicates if technically justified. |
| QuickTest only: low signal despite good standards | Cap/Det Ab not added simultaneously with sample; insufficient mixing after loading | Both Cap/Det Ab and sample must be added to wells and mixed immediately by plate tapping (10 s). Do not pre-incubate Cap/Det Ab in empty wells before adding sample. |